Sign In
Buy EXEL
$51.60
+3.06 (+6.30%)
At Close: Jun 03, 2026
Opdivo in Combination with CABOMETYX Demonstrates Significant Survival Benefits in Patients with Advanced Renal Cell Carcinoma....
Glenmede Trust Co. NA Raises Stock Holdings in Exelixis, Inc. (NASDAQ:EXEL)
08:50am, Friday, 18'th Sep 2020
Glenmede Trust Co. NA increased its position in Exelixis, Inc. (NASDAQ:EXEL) by 1,036.0% in the second quarter, HoldingsChannel.com reports. The fund owned 25,242 shares of the biotechnology company�
Exelixis, Inc. (Nasdaq: EXEL) and Iconic Therapeutics today announced new preclinical data that support the continued development of ICON-2, an ADC co
Regulatory News: Ipsen (Euronext : IPN ; ADR : IPSEY) a annoncé aujourd’hui que de nouvelles données d’essais cliniques et en vie réelle concernant di
Got $5,000? 3 Surefire Stocks to Buy Ahead of the Next Market Crash | The Motley Fool
10:52am, Sunday, 13'th Sep 2020
The long-term picture is bright for these healthcare stocks thanks to stable product revenue.
Exelixis doubles down on ADCs for cancer with NBE, Catalent deals -
09:07pm, Tuesday, 08'th Sep 2020
Exelixis made its name developing small-molecule drugs for cancer, so a new pair of deals focused on antibody-drug
3 Healthcare Stocks to Buy in a Stock Market Crash | The Motley Fool
03:41pm, Tuesday, 08'th Sep 2020
The highly defensive healthcare sector is a smart place to park your cash when volatility picks up.
Exelixis, Inc. (NASDAQ:EXEL) today announced the submission of a supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FD
3 No-Brainer Stocks to Buy That Can Make You Rich | The Motley Fool
10:36am, Saturday, 08'th Aug 2020
These high-growth stocks look to be slam dunks for long-term investors.
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Abiomed (ABMD –
Exelixis' (EXEL) Q2 Earnings and Revenues Surpass Estimates
02:32pm, Friday, 07'th Aug 2020
Exelixis (EXEL) beats on earnings and sales in the second quarter.
Exelixis Inc (EXEL) Q2 2020 Earnings Call Transcript | The Motley Fool
06:01am, Friday, 07'th Aug 2020
EXEL earnings call for the period ending June 30, 2020.
Exelixis (EXEL) Surpasses Q2 Earnings and Revenue Estimates
12:20am, Friday, 07'th Aug 2020
Exelixis (EXEL) delivered earnings and revenue surprises of 75.00% and 11.46%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
Exelixis Announces Second Quarter 2020 Financial Results and Provides Corporate Update
08:05pm, Thursday, 06'th Aug 2020
Exelixis, Inc. (Nasdaq: EXEL) today reported financial results for the second quarter of 2020 and provided an update on progress toward fulfilling its key corporate objectives, as well as commercial a
